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Introduction 
Methods 
Conclusions 
We hypothesized that promoting eNOS coupling and activity with PKCε+/BH4 or inhibiting 
uncoupled eNOS activity with PKCε- would attenuate vascular injury in all vascular 
inflammatory pathologies. We tested this hypothesis in four vascular inflammation models: 
coronary and hindlimb I/R, ESWL, and BH2-induced mesenteric inflammation.  We predict 
that there will be: 1) reduction in PMN adherence and tissue infiltration in the coronary 
vasculature, accompanied by an improvement in post-reperfused cardiac function, 2) 
enhanced endothelial-derived NO and reduced H2O2 blood levels in both hindlimb I/R and 
ESWL and 3) attenuated BH2-induced leukocyte-endothelial interactions in the mesentery. 
Collectively, the data suggest that eNOS uncoupling is a significant and common mechanism 
mediating inflammation in vascular injuries such as coronary and hindlimb I/R, ESWL, and mesenteric 
vascular inflammation. The results from the four vascular inflammation studies support our 
hypothesis that stimulating eNOS activity and promoting coupling using PKCε+/BH4 or attenuating 
eNOS uncoupled activity using PKCε-: 1) significantly attenuated PMN coronary vascular adherence 
and tissue infiltration and improved post-reperfused cardiac function; 2) increased NO and decreased 
H2O2 blood levels in hindlimb I/R and ESWL compared to I/R or ESWL controls; 3) decreased leukocyte 
vascular adherence and tissue infiltration in BH2-induced mesenteric vascular inflammation. By 
contrast, the stimulation of uncoupled eNOS activity using PKCε+/BH2 reversed these effects in these 
four vascular models. These  results suggest that PKCε+/BH4 or PKCε- based therapies may mitigate 
vascular pathologies in the coronary, hindlimb, renal, and mesenteric vasculature. 
Results 
Hindlimb & Renal ESWL Models: NO or H2O2 microsensors were inserted into angiocatheters in the 
rat femoral veins or left renal vein. These microsensors receive an electrical signal proportional to 
the free radical concentration through an oxidation/reduction reaction on the sensor membrane. 
The TBR 4100 Free Radical Analyzer (WPI, Inc., Sarasota, FL) produces a trace of real-time 
measurements of NO or H2O2 release in picoamps (pA) throughout the experiment. NO readings 
were converted to nM, and H2O2 readings were converted to µM based on their own calibration 
curves. All measurements post-I/R or post-ESWL were expressed as relative change from baseline. 
In the hindlimb I/R model, one femoral artery/vein was clamped for 20 min ischemia followed by 
releasing the clamp for 45 min reperfusion. The other femoral artery/vein was a non-ischemic 
sham control (5). In the renal ESWL model, ESWL treatment was administered for 13 min with a 
Dornier Epos Ultra Lithotripter (16kV, 1.3mHz), and measurements were taken through 30 min 
post-ESWL. At reperfusion or immediately following ESWL, 0.5 mL of saline or drug bolus was 
administered via the left jugular vein (4). Experimental groups included a post-I/R or post-ESWL 
infusion of the following: 0.8 mg/kg PKCε-, 0.9 mg/kg PKCε+ with 0.8 mg/kg BH4 (Cayman 
Chemicals), and 0.9 mg/kg PKCε+ with 2 mg/kg BH2 (Cayman Chemicals). 
Vascular Inflammation Model: Intravital microscopy was performed on anesthetized rats. One loop 
of mesentery was placed on a viewing pedestal to observe microcirculation in post-capillary 
venules in real-time. All groups received a superfusion of BH2 over the mesentery to initiate 
inflammation. Leukocyte-endothelial interactions were recorded for 2 min at 30 min intervals after 
baseline.  Superfused mesenteric tissue was harvested at the end of experiment for later 
hematoxylin & eosin (H&E) staining to confirm intravital microscopy observations (6). 
Experimental groups included Krebs’ control, 100μM BH2 control, 100μM BH2 with 10μM PKCε-, 
100μM BH2 with 10μM PKCε+ and 100μM BH4, and 100μM BH2 with 10μM PKCε+. 
Figure 3. Effects of PKCε- or PKCε+ combined with BH4 or BH2 on real-time blood NO and H2O2 release after ESWL. 
ESWL significantly decreased NO release and increased H2O2 release (5-30 min post-ESWL) compared to no-ESWL 
controls. PKCε- administration after ESWL attenuated the ESWL-induced effects resulting in increased NO and 
decreased H2O2 release, similar to no-ESWL controls. Administration of PKCε+/BH4 after ESWL was also similar to no-
ESWL controls, significantly increasing NO and decreasing H2O2release (5-30 min post-ESWL) compared to ESWL 
controls. Post-ESWL infusion of PKCε+/BH2 was similar to the ESWL control group in both NO and H2O2 release. 
(*p≤0.05, **p≤0.01, compared to ESWL controls; #p≤0.05, ##p≤0.01, compared to ESWL with PKCε+/BH2) 
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Coupled eNOS Uncoupled eNOS 
Vascular injury is a key component in the pathogenesis of many diseases such as 
ischemia/reperfusion (I/R), hypertension, and hyperglycemia (1,2).  It also a significant risk 
factor after some medical procedures, such as mechanical vascular trauma induced by 
extracorporeal shock wave lithotripsy (ESWL) that is used to ablate kidney stones (3,4). The 
vascular injury is highlighted with increased oxidative stress (i.e., superoxide [O2-], hydrogen 
peroxide [H2O2]) and serves as an initiating event that reduces nitric oxide (NO) 
bioavailability, and enhances leukocyte-endothelial interactions leading to additional cell 
and organ injury (1,5,6).  Endothelial NO synthase (eNOS) uncoupling (i.e., increased 
dihydrobiopterin [BH2, 239 g/mol] to tetrahydrobiopterin [BH4 , 314 g/mol] ratio) is a source 
of O2- in both  in vitro  and in vivo models (figure 1) (2,5). We have previously shown that 
promoting eNOS coupling by giving BH4 at the beginning of reperfusion significantly 
improves post-reperfused cardiac function and reduces of polymorphonuclear leukocyte 
(PMN) infiltratrion in isolated perfused I/ R hearts.  Moreover, BH4 significantly enhanced 
NO and reduced H2O2 blood levels during hind limb I/R in vivo (5).  These findings led us to 
explore the combination of modulating eNOS activity and coupling in myocardial and hind 
limb I/R,  ESWL, and mesenteric inflammation models. Cell-permeable protein kinase C 
epsilon peptide activator (PKCε+, N-Myr-HDAPIGYD, 1097 g/mol) increases eNOS activity 
while PKCε inhibitor (PKCε-, N-Myr-EAVSLKPT, 1054 g/mol) reduces eNOS activity. Using a 
combination of eNOS cofactors BH4 or BH2 with PKCε+ we explored the role of promoting 
eNOS coupling/uncoupling on oxidative stress in I/R, ESWL, and  BH2-induced leukocyte-
endothelial interactions in the rat mesenteric circulation. We also explored the role of 
inhibiting uncoupled eNOS  using PKCε- in these four animal models.  
Figure 1. Coupled eNOS and Uncoupled eNOS. BH4 is the cofactor of coupled eNOS which produces NO. 
Oxidative stress results in an increased BH2:BH4 ratio. BH2 is the cofactor for uncoupled eNOS which 
produces superoxide (O2-) which is then converted to H2O2 by superoxide dismutase {adapted from 2} 
Figure 2. Relative difference in blood NO and H2O2 release between I/R and sham femoral veins during reperfusion 
in saline controls, PKCε-, PKCε+/BH4, or PKCε+/BH2 treated groups. By contrast to saline group, PKCε- significantly 
increased NO and decreased H2O2 and PKCε+/BH4 significantly decreased H2O2 from 10-45 min  and increased NO 
at 20 min reperfusion; whereas PKCε+/BH2 significantly decreased NO from 25-40 min and  increased H2O2, (not 
significant).  (*p≤0.05, **p≤0.01, compared to  saline controls) 
BH2 + PKCε-   BH2 + BH4 + PKCε+  Krebs’ Buffer BH2  BH2 + PKCε+ 
Figure  4. Representative pictures of leukocyte 
adherence (arrow) and transmigration (arrow 
head) by H&E staining of mesenteric tissues from 
experimental  groups (top). Compared to Krebs’, 
the BH2 group exhibited a significant increase in 
adhered and transmigrated leukocytes.  By  
contrast, PKCε+/BH4  or PKCε- significantly 
decreased the BH2  induced  effects on these 
parameters. (*P<0.05,**P<0.01 from Krebs; 
#P<0.05, ##P<0.01 from 100 µM BH2)  
Group Total Intravascular and Infiltrated PMNs 
I/R + PMNs control 193.2 ± 7.3 
I/R + PMNs + PKCε- 111.5 ± 11.0* 
I/R + PMNs + PKCε+/BH4 86.1 ± 6.4* 
I/R + PMNs + PKCε+/BH2 142.3 ± 12.8 
The infiltration of PMNs into  the myocardium 
closely correlated with cardiac contractile 
dysfunction associated with I/R. PKCε- or  
PKCε+/BH4 treated hearts significantly 
attenuated PMN infiltration and  was 
associated with improved post-reperfused 
cardiac function. (*p<0.01 from total 
intravascular and infiltrated I/R + PMN values) 
 
Group Initial LVDP Final LVDP Initial +dP/dtmax Final +dP/dtmax 
I/R + PMNs control (n=11) 94.4 ± 4.1 42.0 ± 5.8# 2469.2 ± 116.9  807.9 ± 97.8# 
I/R + PMNs + 5μM PKCε- (n=7) 91.1 ± 2.6 90.0 ± 4.9** 2505.9 ± 97.7 2240.5 ± 103.4** 
I/R + PMNs + 10μM PKCε+/5μM BH4 (n=7) 85.3 ± 1.2 78.8 ± 9.4* 2174.6 ± 56.5  1806.6 ± 157.8** 
I/R + PMNs + 10μM PKCε+/100μM BH2 (n=6) 92.6 ± 2.2 35.2 ± 8.4  2438.4 ± 105.3 751.4 ± 204.9 
Table 1. Initial and Final LVDP and +dP/dtmax among Different Experimental Groups  
  
There was no significant difference between initial baseline values of left ventricular developed pressure (LVDP) 
and +dP/dTmax in all study groups. I/R + PMNs hearts recovered to only 45% and 31% of LVDP and +dP/dtmax, 
respectively. Addition of PKCε- resulted in almost complete recovery for both LVDP and +dP/dtmax. Similarly, I/R + 
PMNs + PKCε+/BH4 recovered to 92% and 83% for LVDP and +dP/dtmax, respectively. In contrast, I/R + PMNs + 
PKCε+/BH2 hearts recovered to 38% for LVDP and 31% for +dP/dtmax  similar to controls. (#p<0.01 compared to 
initial LVDP or +dP/dtmax of I/R+PMN group; *p<0.05, **p<0.01 compared to I/R+PMN final LVDP or +dP/dtmax) 
Table 2. Histological Assessments of PMNs in Isolated Perfused Rat Hearts  
 Effects of PKCε-, PKCε+/BH4, and PKCε+/BH2 on NO/H2O2 blood levels in Hindlimb I/R:  
Leukocyte vascular adherence/transmigration in superfused mesenteric tissues: 
 Effects of PKCε-, PKCε+/BH4, and PKCε+/BH2 on NO/H2O2 blood levels post-ESWL: 
Experiments were performed on male Sprague-Dawley rats (275-325g, Charles River, 
Springfield, MA) which were anesthetized with sodium pentobarbital (60 mg/kg) 
intraperitoneally. A maintenance dose (30 mg/kg) was administered as needed. All data was 
presented as means ±SEM. The data for each time-point were compared by ANOVA using 
post-hoc analysis with the Bonferroni/Dunn test (coronary data), Student Newman Keuls 
test (hindlimb and ESWL data), and Fisher’s PLSD test (mesenteric data). Probability values 
of less than 0.05 were considered to be statistically significant. 
Coronary I/R Model: Hearts were rapidly excised, and retrograde perfusion of the hearts 
was initiated with modified Kreb’s Buffer and maintained at 80 mmHg pressure at 37oC. 
After a stable baseline was established, hearts were subjected to I (20 min)/R (45 min) and 
given PMNs (200x106) and plasma in the presence or absence of drug given at reperfusion 
(5). Experimental groups included I/R + PMNs (control), I/R + PMNs + PKCε- (Genemed 
Synthesis), I/R + PMNs + PKCε+ (Genemed Synthesis) /BH4, and I/R + PMNs + PKCε+/BH2.  
